Literature DB >> 16696002

Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease.

A Santón1, A I Manzanal, E Campo, C Bellas.   

Abstract

Aims-To analyse the latent membrane protein-1 (LMP-1) gene in a series of patients with Epstein-Barr virus (EBV) positive LMP expressing ordinary and HIV associated Hodgkin's disease to detect possible genetic alterations and particularly the existence of deletions near the 3' end of the gene.Methods-Expression of the EBV LMP-1 was assessed using immunohistochemistry in 186 cases of Hodgkin's disease and 31 cases of HIV associated Hodgkin's disease. Genomic DNA was extracted from frozen lymph node biopsy specimens from 25 cases of Hodgkin's disease and 11 of HIV associated Hodgkin's disease, all of whom expressed the LMP-1 protein within diagnostic Hodgkin and Reed-Sternberg (HRS) cells, and amplified by polymerase chain reaction (PCR) using primers specific for the different LMP-1 regions.Results-LMP-1 expression was observed in 106 of 186 Hodgkin's disease cases and in all 31 HIV associated Hodgkin's disease cases. Molecular analysis of the LMP-1 gene showed a high degree of genetic heterogeneity in the carboxy-terminal domain compared with the prototype B95-8 EBV strain, specially in the patients with HIV associated Hodgkin's disease. Variation in the size of the repeated region was found in 17 of 25 Hodgkin's disease and nine of 11 HIV associated Hodgkin's disease cases. Deletions of 30 base pairs near the 3' end of the gene were detected in all cases of HIV associated Hodgkin's disease and in six Hodgkin's disease. In one case of Hodgkin's disease a larger deletion was observed. In all patients with LMP-1 deletion mutants, 50-90% of the diagnostic HRS cells expressed the LMP-1 protein.Conclusions-The presence of the 30 base pair deletion in all cases of HIV associated Hodgkin's disease supports previous studies that reported aggressive histological and clinical behaviour in tumours harbouring this deletion. This deletion may prolong the half-life of the protein which would explain the high levels of LMP-1 expressing HRS cells in those cases carrying LMP-1 deletions. That the 30 base pair deletion was present in all of the HIV associated Hodgkin's disease specimens suggests that impairment of immune function is a stringent requirement for the expansion of malignant cells infected by EBV strains containing the deleted LMP-1 gene.

Entities:  

Year:  1995        PMID: 16696002      PMCID: PMC407958          DOI: 10.1136/mp.48.4.m184

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN: 1355-2910


  33 in total

1.  Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation.

Authors:  K M Izumi; K M Kaye; E D Kieff
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

2.  Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

3.  Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid.

Authors:  R Rubio
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

4.  Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma.

Authors:  H Knecht; E Bachmann; P Brousset; K Sandvej; D Nadal; F Bachmann; B F Odermatt; G Delsol; G Pallesen
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

5.  Sequence variation in the Epstein-Barr virus latent membrane protein 1.

Authors:  W E Miller; R H Edwards; D M Walling; N Raab-Traub
Journal:  J Gen Virol       Date:  1994-10       Impact factor: 3.891

6.  Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease.

Authors:  H Knecht; E Bachmann; D J Joske; R Sahli; A Eméry-Goodman; J L Casanova; M Zilić; F Bachmann; B F Odermatt
Journal:  Leukemia       Date:  1993-04       Impact factor: 11.528

7.  Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas.

Authors:  K Sandvej; S C Peh; B S Andresen; G Pallesen
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

8.  The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.

Authors:  G Mosialos; M Birkenbach; R Yalamanchili; T VanArsdale; C Ware; E Kieff
Journal:  Cell       Date:  1995-02-10       Impact factor: 41.582

9.  Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise.

Authors:  M J Boyle; E Vasak; M Tschuchnigg; J J Turner; T Sculley; R Penny; D A Cooper; B Tindall; W A Sewell
Journal:  Blood       Date:  1993-01-15       Impact factor: 22.113

10.  All three domains of the Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts.

Authors:  R K Moorthy; D A Thorley-Lawson
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  5 in total

1.  Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.

Authors:  K Sandvej; B S Andresen; X G Zhou; N Gregersen; S Hamilton-Dutoit
Journal:  Mol Pathol       Date:  2000-10

2.  Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders.

Authors:  A G Scheinfeld; R G Nador; E Cesarman; A Chadburn; D M Knowles
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

Review 3.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

4.  Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.

Authors:  Do Nguyen-Van; Ingemar Ernberg; Ingemar Enrberg; Phi Phan-Thi Phi; Chinh Tran-Thi; LiFu Hu
Journal:  Virus Genes       Date:  2008-07-29       Impact factor: 2.332

5.  Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.

Authors:  Hui Shien See; Yoke Yeow Yap; Wai Kien Yip; Heng Fong Seow
Journal:  World J Surg Oncol       Date:  2008-02-15       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.